Healthcare ETFs news and market signals

Medtronic has projected robust organic revenue growth of 6.75% to 7.25% for fiscal year 2027. The medical device giant also anticipates earnings per share between $5.90 and $6.00, despite an estimated $250 million impact from tariffs.